Finland· FI-REL-REL8218

Diabinese

A chlorpropamide product, registered in Finland by PFIZER. The same ATC class is registered in 3 of our 19 countries.

ATC A10BB02

Checked against Fimea (Finland) on September 27, 2026

Informational only — not a medical device.

Compare price across countriesPer daily dose · free account Ask the assistant about DiabineseAnswers with sources · free account Check interactionsSeverity free · mechanism on Growth

Where it is registered

Chlorpropamide is registered in 3 of 19 countries.

Countries holding a registration under ATC A10BB02 (chlorpropamide), each read from that country’s own register.

This record: Finland, from Fimea (Finland)
1 of them publish a price we can compare per daily dose

Search chlorpropamide products by name

Chlorpropamide · ATC A10BB02

3 / 19 countries

Finlandprice
Japan
United Kingdom

Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

Fimea (Finland)

Manufacturer: PFIZER
Country: Finland (FI)
ATC code: A10BB02
ATC class: Chlorpropamide
Defined daily dose: 0.375 g, O
Reimbursed: Not published by this register
Source register: Fimea (Finland)
Last checked: September 27, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

542 interactions on record for chlorpropamide.

Graded by severity as the source publishes them — 20 severe. Severity grades are free for everyone; mechanism and management come with Growth.

Severity for every pair — free, no plan needed
The source, licence and sync date on every record
Mechanism and what to do for each pair — Growth plan

Check chlorpropamide against other medicines How interaction checks work

Chlorpropamide · interactions on record

542 records

20 severe
454 moderate
53 minor
15 info

Most severe, free to view

MiconazoleA07AC01severe
Magnesium carbonateA02AA01moderate
Magnesium oxideA02AA02moderate
Magnesium hydroxideA02AA04moderate

Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.

Mechanism and what to do, in the interaction check

Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same class

Other records under A10BB02

Chlorpropamide, as other registers publish it.

All chlorpropamide products

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Fimea (Finland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload

GET /v1/drugs/51f78687-f99f-421f-83f4-a2c981c37e23
GET /v1/drugs/51f78687-f99f-421f-83f4-a2c981c37e23?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "ddd": "0.375",
  "form": "tabletti",
  "route": null,
  "ddd_unit": "g",
  "strength": "250 mg",
  "atc_label": "klooripropamidi",
  "ma_number": "891",
  "auth_status": "Myyntilupa peruuntunut",
  "eu_ma_number": null,
  "fimea_rel_id": "REL8218",
  "authorised_at": "1965-02-03"
}

API reference MCP server Plans

See everything about chlorpropamide.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it free Open in the console